You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enteric hyperoxaluria

Showing 1 - 25 of 447
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)

Recruiting
  • Enteric Hyperoxaluria
  • Moderately High Oxalate (MOx) Diet
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)

Recruiting
  • Healthy
  • Enteric Hyperoxaluria
  • FB-001
  • Placebo
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 23, 2023

Healthy Volunteers, Enteric Hyperoxaluria Trial in Canada, United States (combination product, biological, drug)

Recruiting
  • Healthy Volunteers
  • Enteric Hyperoxaluria
  • NOV-001
  • +3 more
  • Birmingham, Alabama
  • +14 more
Jun 24, 2022

Healthy, Enteric Hyperoxaluria Trial in United States (SYNB8802, Placebo)

Recruiting
  • Healthy
  • Enteric Hyperoxaluria
  • Tucson, Arizona
  • +3 more
May 11, 2021

Enteric Hyperoxaluria Trial in Austin (SYNB8802v1, Placebo)

Recruiting
  • Enteric Hyperoxaluria
  • Austin, Texas
    PPD, part of Thermo Fisher Scientific
May 11, 2022

Enteric Hyperoxaluria, Primary Hyperoxaluria, Hyperoxalemia Trial in Germany, United Kingdom, United States (ALLN-177)

Completed
  • Enteric Hyperoxaluria
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Dec 29, 2020

Enteric Hyperoxaluria, Hyperoxaluria Trial in Rochester (C-13 labeled oxalate)

Completed
  • Enteric Hyperoxaluria
  • Hyperoxaluria
  • C-13 labeled oxalate
  • Rochester, Minnesota
    Mayo Clinic Rochester
Feb 28, 2020

Prospective Research Rare Kidney Stones (ProRKS)

Recruiting
  • Hyperoxaluria
  • +4 more
    • Birmingham, Alabama
    • +10 more
    Nov 10, 2022

    Enteric Hyperoxaluria Trial in Worldwide (ALLN-177, Placebo)

    Completed
    • Enteric Hyperoxaluria
    • Birmingham, Alabama
    • +62 more
    Feb 25, 2020

    Secondary Hyperoxaluria, Nephrolithiasis, Hyperoxaluria Trial in United States (Test Meal)

    Completed
    Has Results
    • Secondary Hyperoxaluria
    • +3 more
    • Test Meal
    • Tucson, Arizona
    • +4 more
    Oct 5, 2021

    Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)

    Completed
    Has Results
    • Primary Hyperoxaluria
    • Oxalobacter formigenes
    • Bonn, Germany
      Universitätsklinikum Bonn, Department of Paediatric Nephrology
    Dec 9, 2021

    Kidney Calculi, Crohn's Disease Trial in Vancouver (Calcium Carbonate)

    Recruiting
    • Kidney Calculi
    • Crohn's Disease
    • Calcium Carbonate
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    May 16, 2022

    Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

    Recruiting
    • Hyperoxaluria
    • +2 more
    • BMN 255
    • Placebo
    • Birmingham, Alabama
    • +6 more
    Nov 16, 2023

    Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)

    Completed
    • Helicobacter Pylori Infection
    • Chang chun, Jilin, China
      The First Hospital of Jilin University
    Oct 7, 2023

    PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

    Active, not recruiting
    • PH1
    • +4 more
    • Bordeaux, France
    • +8 more
    Jan 13, 2023

    Lupus Nephritis Trial (Mescaline sodium enteric-coated tablets, Morte-mescaline, Glucocorticoids)

    Not yet recruiting
    • Lupus Nephritis
    • Mescaline sodium enteric-coated tablets
    • +2 more
    • (no location specified)
    Jul 5, 2023

    Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)

    Completed
    • Helicobacter Pylori Infection
    • Chang chun, Jilin, China
      The First Hospital of Jilin University
    Oct 7, 2023

    Menopause Trial in Gig Harbor (ERr 731 - Micro-coated, ERr 731 - Enteric coated)

    Active, not recruiting
    • Menopause
    • ERr 731 - Micro-coated
    • ERr 731 - Enteric coated
    • Gig Harbor, Washington
      Personalized Lifestyle Medicine Center
    Jul 15, 2023

    Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

    Recruiting
    • Cystinosis
    • Primary Hyperoxaluria
    • Diagnostic test
    • Hanover, Lower Saxony, Germany
      Screening Laboratory Hanover
    Apr 24, 2023

    Glioblastoma Trial in Beijing (PLB1001, Temozolomide, Cisplatin combined with Etoposide)

    Active, not recruiting
    • Glioblastoma
    • Beijing, Beijing, China
      Beijing Tiantan Hospital,Capital Medical University
    Oct 27, 2023

    Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

    Available
    • Primary Hyperoxaluria Type 1 (PH1)
    • (no location specified)
    Aug 7, 2023

    Achalasia Trial (ValACYclovir 1000 MG, Shingrix)

    Not yet recruiting
    • Achalasia
    • ValACYclovir 1000 MG
    • Shingrix
    • (no location specified)
    Jan 17, 2023

    MDD (MDD) Trial (Ammoxetine, Placebo)

    Not yet recruiting
    • Major Depressive Disorder (MDD)
    • (no location specified)
    Feb 28, 2023

    Reflux Esophagitis Trial in Guangzhou (DWP14012)

    Completed
    • Reflux Esophagitis
    • Guangzhou, Guangdong, China
      Minhu Chen
    Apr 2, 2023

    Osteoarthritis, Knee Trial in Columbia (Enteric coated Devil's Claw, Non-enteric coated Devil's Claw)

    Withdrawn
    • Osteoarthritis, Knee
    • Enteric coated Devil's Claw
    • Non-enteric coated Devil's Claw
    • Columbia, Missouri
      Univ of Missouri Health Care Center
    May 19, 2022